Wednesday, August 19, 2026

QNTM Day Wrap — August 19, 2026

The QNTM model portfolio slipped -0.31% today while SPY edged up +0.19%, a roughly 50bp gap on a session where the tape's gains were narrow and defensive.

What drove it: Gains were broad on most sectors, with software application and hyperscalers mostly trading higher, and Apple, Salesforce, and Tesla gained 1%. But the real lift came from names outside typical high-conviction screens: retail stocks gained after TJX, Target, and Lowe's all reported second-quarter earnings, and Moderna stock prices doubled while Merck surged 10% after a trial on their joint vaccine cut recurrence in melanoma. Merck led Dow gains (+10.20%), while Caterpillar, Goldman Sachs and JPMorgan were among the laggards. With QNTM's universe averaging a middling 50.1 conviction score and only 4.1% of ~1,422 names scoring high-conviction, the model's 50-stock sleeve had limited exposure to the healthcare/vaccine surprise and retail-earnings pop that carried the index — a diversification-vs-concentration mismatch rather than a broad market call being wrong.

Market recap: Most shares in the S&P 500 rose, though chipmakers dropped once again , keeping the Nasdaq soft even as the broader tape firmed. Backdrop stayed tense: tariff and Middle East headlines kept a bid under oil (WTI ~$84) while VIX held low near 15, and 30-year yields hovered near multi-decade highs after Tuesday's spike.

What's next: Watch whether healthcare/retail leadership broadens or fades, and whether easing Treasury-yield pressure lets semis stabilize — both would matter for the model's next rebalance. This is research, not a recommendation.